{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:20:18Z","timestamp":1790572818769,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["[2023]112"],"award-info":[{"award-number":["[2023]112"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["2024001"],"award-info":[{"award-number":["2024001"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["J2021032"],"award-info":[{"award-number":["J2021032"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prp.2026.156516","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T14:26:00Z","timestamp":1778423160000},"page":"156516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nitric oxide pathway: Emerging therapeutic strategies for MASLD"],"prefix":"10.1016","volume":"284","author":[{"given":"Yanling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156516_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2026.156516_bib2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2026.156516_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib6","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.prp.2026.156516_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35338","article-title":"From MASLD to HCC: What's in the middle?","volume":"10","author":"Provera","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2026.156516_bib8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatol. (Baltim. Md)"},{"key":"10.1016\/j.prp.2026.156516_bib9","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41598-025-91312-5","article-title":"Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021","volume":"15","author":"Guo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156516_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1421386","article-title":"Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease","volume":"11","author":"Chen","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.prp.2026.156516_bib11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamainternmed.2024.4661","article-title":"GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"184","author":"Kanwal","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.prp.2026.156516_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4103\/mgr.MEDGASRES-D-24-00100","article-title":"Inhibition of hepatic gluconeogenesis in type 2 diabetes by metformin: complementary role of nitric oxide","volume":"15","author":"Farahani","year":"2025","journal-title":"Med Gas. Res"},{"key":"10.1016\/j.prp.2026.156516_bib13","article-title":"Advances in the Regulation of Inflammatory Mediators in Nitric Oxide Synthase: Implications for Disease Modulation and Therapeutic Approaches","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156516_bib14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4103\/mgr.MEDGASRES-D-24-00144","article-title":"Nitric oxide: a gas transmitter in healthy and diseased skin","volume":"15","author":"Zaborova","year":"2025","journal-title":"Med Gas. Res"},{"key":"10.1016\/j.prp.2026.156516_bib15","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.3748\/wjg.v23.i37.6777","article-title":"Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction","volume":"23","author":"Pasar\u00edn","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2026.156516_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","article-title":"Nitric oxide in liver diseases","volume":"36","author":"Iwakiri","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.prp.2026.156516_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3350\/cmh.2015.21.4.319","article-title":"Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase","volume":"21","author":"Iwakiri","year":"2015","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","article-title":"Nitric oxide in liver diseases","volume":"36","author":"Iwakiri","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.prp.2026.156516_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"10.1016\/j.prp.2026.156516_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051406","article-title":"The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"13","author":"Minciuna","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2026.156516_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1114","article-title":"Inducible nitric oxide synthase accelerates nonalcoholic fatty liver disease progression by regulating macrophage autophagy","volume":"11","author":"Jin","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.prp.2026.156516_bib24","first-page":"815","article-title":"Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism","volume":"12","author":"Feng","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s43440-022-00380-1","article-title":"Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5\/Dmcr rat via acceleration of abnormal lipid metabolism","volume":"74","author":"Sato","year":"2022","journal-title":"Pharmacol. Rep. PR"},{"key":"10.1016\/j.prp.2026.156516_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.niox.2025.05.004","article-title":"The association between serum and urinary nitric oxide metabolites and fatty liver index: a population-based study","volume":"158","author":"Bahadoran","year":"2025","journal-title":"Nitric Oxide Biol. Chem."},{"key":"10.1016\/j.prp.2026.156516_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10517-024-06066-3","article-title":"Blood Level of Nitric Oxide Metabolites and Expression of Genes Regulating NO Synthesis in Early Forms of Non-Alcoholic Fatty Liver Disease","volume":"176","author":"Kurbatova","year":"2024","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.prp.2026.156516_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2026.156516_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040266","article-title":"Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy","volume":"14","author":"Sharip","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156516_bib30","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4254\/wjh.v15.i12.1258","article-title":"Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review","volume":"15","author":"Chen","year":"2023","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-0716-3207-9_17","article-title":"Hepatic Stellate Cell Targeting Using Peptide-Modified Biologicals","volume":"2669","author":"Bansal","year":"2023","journal-title":"Methods Mol. Biol. (Clifton NJ)"},{"key":"10.1016\/j.prp.2026.156516_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jcb.30403","article-title":"Arginase 1 expression is increased during hepatic stellate cell activation and facilitates collagen synthesis","volume":"124","author":"Zhang","year":"2023","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2026.156516_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1444198","article-title":"Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy","volume":"12","author":"Tian","year":"2024","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156516_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1114","article-title":"Inducible nitric oxide synthase accelerates nonalcoholic fatty liver disease progression by regulating macrophage autophagy","volume":"11","author":"Jin","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.prp.2026.156516_bib35","article-title":"Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2026.156516_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat. Rev. Gastroenterol. & Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2024.02.022","article-title":"Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis","volume":"368","author":"Wang","year":"2024","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.prp.2026.156516_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jconrel.2025.01.036","article-title":"Targeted delivery of polymeric NO-donor micelles to hepatic stellate cells for restoration of liver function and inhibition of hepatic fibrosis","volume":"379","author":"Yang","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.prp.2026.156516_bib39","first-page":"427","article-title":"NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension","volume":"57","author":"Vairappan","year":"2024","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"10.1016\/j.prp.2026.156516_bib40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.32332","article-title":"Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase","volume":"76","author":"Fang","year":"2022","journal-title":"Hepatol. (Baltim. Md)"},{"key":"10.1016\/j.prp.2026.156516_bib41","first-page":"73","article-title":"Relaxin Inhibits Angiotensin II-Induced Cardiac Fibrosis by Activating NO\/cGMP Signaling Pathway","volume":"29","author":"Liu","year":"2024","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.prp.2026.156516_bib42","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41374-019-0240-y","article-title":"Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease","volume":"99","author":"Lee","year":"2019","journal-title":"Lab. Investig. a J. Tech. Methods Pathol."},{"key":"10.1016\/j.prp.2026.156516_bib43","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1152\/japplphysiol.01275.2013","article-title":"Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats","volume":"116","author":"Sheldon","year":"2014","journal-title":"J. Appl. Physiol. (Bethesda Md 1985)"},{"key":"10.1016\/j.prp.2026.156516_bib44","doi-asserted-by":"crossref","first-page":"E605","DOI":"10.1152\/ajpendo.00096.2019","article-title":"eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH","volume":"317","author":"Sheldon","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2026.156516_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12876-015-0409-9","article-title":"Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution","volume":"15","author":"Nozaki","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.prp.2026.156516_bib46","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.2337\/db20-1228","article-title":"Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH","volume":"70","author":"Cunningham","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2026.156516_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2026.156516_bib49","article-title":"A \"Cocktail\" Fluorescent Probe for Multi-ROS Imaging Unveils Ferroptosis-Driven Liver Fibrosis Development","volume":"64","author":"Wang","year":"2025","journal-title":"Angew. Chem. (Int. Ed. Engl. )"},{"key":"10.1016\/j.prp.2026.156516_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s43556-024-00184-0","article-title":"Signaling pathways in liver cancer: pathogenesis and targeted therapy","volume":"5","author":"Xue","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.prp.2026.156516_bib51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2026.156516_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2022.07.006","article-title":"Impact of nitric oxide in liver cancer microenvironment","volume":"128","author":"Dios-Barbeito","year":"2022","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.prp.2026.156516_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.niox.2022.07.006","article-title":"Impact of nitric oxide in liver cancer microenvironment","volume":"128","author":"Dios-Barbeito","year":"2022","journal-title":"Nitric Oxide Biol. Chem."},{"key":"10.1016\/j.prp.2026.156516_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.actbio.2021.01.015","article-title":"NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies","volume":"123","author":"Ding","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.prp.2026.156516_bib55","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1038\/s41591-024-02958-z","article-title":"Opportunities and challenges following approval of resmetirom for MASH liver disease","volume":"30","author":"Lazarus","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2026.156516_bib56","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2026.156516_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2026.156516_bib58","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/s41401-024-01303-x","article-title":"A new mechanism of thyroid hormone receptor \u03b2 agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles","volume":"45","author":"Sun","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.prp.2026.156516_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13061315","article-title":"Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation","volume":"13","author":"Liu","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2026.156516_bib60","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/HEP.0000000000001084","article-title":"Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis","volume":"81","author":"Younossi","year":"2024","journal-title":"Hepatol. (Baltim. Md)"},{"key":"10.1016\/j.prp.2026.156516_bib61","doi-asserted-by":"crossref","first-page":"11057","DOI":"10.1073\/pnas.1821045116","article-title":"sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH","volume":"116","author":"Hall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2026.156516_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010382","article-title":"Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats","volume":"22","author":"Broermann","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156516_bib63","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1002\/ejhf.70033","article-title":"Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial","volume":"27","author":"Mentz","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.prp.2026.156516_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.healun.2024.08.018","article-title":"Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials","volume":"44","author":"Rosenkranz","year":"2024","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.prp.2026.156516_bib65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.prp.2026.156516_bib66","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/CIRCULATIONAHA.108.800292","article-title":"Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure","volume":"119","author":"Lapp","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2026.156516_bib67","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00345-020-03233-9","article-title":"Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis","volume":"39","author":"Madeira","year":"2020","journal-title":"World J. Urol."},{"key":"10.1016\/j.prp.2026.156516_bib68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/sxmrev\/qeae043","article-title":"Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium","volume":"12","author":"Rosen","year":"2024","journal-title":"Sex. Med. Rev."},{"key":"10.1016\/j.prp.2026.156516_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/foods10061314","article-title":"Current Knowledge on Beetroot Bioactive Compounds: Role of Nitrate and Betalains in Health and Disease","volume":"10","author":"Milton-Laskibar","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.prp.2026.156516_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.109032","article-title":"Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease","volume":"711","author":"Liu","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.prp.2026.156516_bib71","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.freeradbiomed.2025.07.002","article-title":"Ageing modifies the oral microbiome, nitric oxide bioavailability and vascular responses to dietary nitrate supplementation","volume":"238","author":"Vanhatalo","year":"2025","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.prp.2026.156516_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1181706","article-title":"Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials","volume":"10","author":"Fateh","year":"2023","journal-title":"Front Nutr."},{"key":"10.1016\/j.prp.2026.156516_bib73","doi-asserted-by":"crossref","first-page":"938","DOI":"10.14336\/AD.2017.1207","article-title":"Nitrate and Nitrite in Health and Disease","volume":"9","author":"Ma","year":"2018","journal-title":"Aging Dis."},{"key":"10.1016\/j.prp.2026.156516_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13668-025-00678-5","article-title":"Nitrate and Nitrite in the Diet: Protective and Harmful Effects in Health and Disease","volume":"14","author":"Sokal-Dembowska","year":"2025","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.prp.2026.156516_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172618","article-title":"Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK\/SIRT1 signaling pathway in HepG2 cells","volume":"861","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prp.2026.156516_bib76","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.116875","article-title":"Effect of Quercetin on the Expression of NOXs and P-Smad3C in TGF-\u0392-Activated Hepatic Stellate Cell Line LX-2","volume":"21","author":"Mohammadtaghvaei","year":"2021","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.prp.2026.156516_bib77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejphar.2014.06.006","article-title":"Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats","volume":"738","author":"Xin","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prp.2026.156516_bib78","article-title":"Sappanone A Alleviates the Severity of Carbon Tetrachloride-Induced Liver Fibrosis in Mice","volume":"12","author":"Qi","year":"2023","journal-title":"Antioxid. (Basel Switz. )"},{"key":"10.1016\/j.prp.2026.156516_bib79","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1142\/S0192415X13500560","article-title":"Ligusticum chuanxiong prevents ovariectomy-induced liver and vascular damage in rats","volume":"41","author":"Li","year":"2013","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.prp.2026.156516_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/nu11123035","article-title":"Semen Cuscutae Administration Improves Hepatic Lipid Metabolism and Adiposity in High Fat Diet-Induced Obese Mice","volume":"11","author":"Moon","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2026.156516_bib81","article-title":"New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells","volume":"25","author":"Vergani","year":"2020","journal-title":"Mol. (Basel Switz. )"},{"key":"10.1016\/j.prp.2026.156516_bib82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vph.2016.12.003","article-title":"G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE-\/- mice","volume":"89","author":"Qian","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.prp.2026.156516_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.537061","article-title":"Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice","volume":"11","author":"Cruz","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2026.156516_bib84","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1017\/S0007114516004025","article-title":"Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation","volume":"116","author":"Jin","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.prp.2026.156516_bib85","article-title":"Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis","volume":"12","author":"Ahsan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.prp.2026.156516_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500196","article-title":"Ultrasound-Mediated Biomimetic Microbubbles Effectively Reverse LSECs Capillarization and Exert Antiplatelet Therapy in Liver Fibrosis","volume":"14","author":"Deng","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.prp.2026.156516_bib87","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/17512433.2025.2600410","article-title":"Efficacy and safety of statins for nonalcoholic\/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis","volume":"18","author":"Fang","year":"2025","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.prp.2026.156516_bib88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12876-015-0269-3","article-title":"Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model","volume":"15","author":"Nozaki","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.prp.2026.156516_bib89","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2019.04.144","article-title":"Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1","volume":"514","author":"Qiao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2026.156516_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412056","article-title":"iNOS in Macrophage Polarization: Pharmacological and Regulatory Insights","volume":"26","author":"Kang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156516_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107781","article-title":"Inducible nitric oxide synthase (iNOS): More than an inducible enzyme? Rethinking the classification of NOS isoforms","volume":"216","author":"Farahani","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.prp.2026.156516_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.14797\/mdcj-15-3-200","article-title":"Inorganic Nitrate Supplementation for Cardiovascular Health","volume":"15","author":"Ivy","year":"2019","journal-title":"Methodist DeBakey Cardiovasc. J."},{"key":"10.1016\/j.prp.2026.156516_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020236","article-title":"Effects of Animal-Based and Plant-Based Nitrates and Nitrites on Human Health: Beyond Nitric Oxide Production","volume":"15","author":"Membrino","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156516_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1648219","article-title":"Interplay between dietary nitrate metabolism and proton pump inhibitors: impact on nitric oxide pathways and health outcomes","volume":"12","author":"Basaqr","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.prp.2026.156516_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115937","article-title":"Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS\/MS and its application in the clinical determination in patients with tumors associated with overactive bladder","volume":"240","author":"Lou","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.prp.2026.156516_bib96","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/ajh.26340","article-title":"Recommendations for diagnosis and treatment of methemoglobinemia","volume":"96","author":"Iolascon","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.prp.2026.156516_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.meatsci.2016.03.009","article-title":"Dietary nitrate and nitrite: Benefits, risks, and evolving perceptions","volume":"120","author":"Bedale","year":"2016","journal-title":"Meat Sci."},{"key":"10.1016\/j.prp.2026.156516_bib98","doi-asserted-by":"crossref","first-page":"H1478","DOI":"10.1152\/ajpheart.00739.2001","article-title":"Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery","volume":"282","author":"Kubo-Inoue","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.prp.2026.156516_bib99","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1476-5381.2011.01500.x","article-title":"Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis","volume":"164","author":"Capettini","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prp.2026.156516_bib100","article-title":"LSA-DDI: Learning Stereochemistry-Aware Drug Interactions via 3D Feature Fusion and Contrastive Cross-Attention","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156516_bib101","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1109\/TCBB.2022.3143770","article-title":"Inferring Latent MicroRNA-Disease Associations on a Gene-Mediated Tripartite Heterogeneous Multiplexing Network","volume":"19","author":"Li","year":"2022","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform"},{"key":"10.1016\/j.prp.2026.156516_bib102","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41565-019-0570-3","article-title":"Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies","volume":"14","author":"Sung","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.prp.2026.156516_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116143","article-title":"Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats","volume":"171","author":"Perram\u00f3n","year":"2024","journal-title":"Biomed. Pharm."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:25:02Z","timestamp":1783085102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382600169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":103,"alternative-id":["S034403382600169X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156516","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide pathway: Emerging therapeutic strategies for MASLD","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156516"}}